Volume 10, Issue 6, Pages (December 2006)

Slides:



Advertisements
Similar presentations
Chapter 7 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Advertisements

Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data  Julia L. Williams, Peter A. Greer,
Volume 12, Issue 5, Pages (November 2007)
Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors  Anita Muthukaruppan, Annette Lasham,
Functional Genomics Analysis Reveals a MYC Signature Associated with a Poor Clinical Prognosis in Liposarcomas  Dat Tran, Kundan Verma, Kristin Ward,
Volume 129, Issue 3, Pages (September 2005)
Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer  C.E. Henry, C. Emmanuel, N.
Volume 52, Issue 1, Pages (July 2007)
Volume 5, Issue 1, Pages (October 2013)
Volume 12, Issue 5, Pages (November 2007)
Volume 131, Issue 6, Pages (December 2006)
The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer
Volume 150, Issue 4, Pages (April 2016)
A Mitochondrial Power Play in Lymphoma
Volume 2, Issue 4, Pages (April 2008)
Volume 46, Issue 2, Pages (February 2017)
Volume 17, Issue 1, Pages (January 2010)
Mariëlle I. Gallegos Ruiz, MSc, Hester van Cruijsen, MD, Egbert F
Volume 7, Issue 4, Pages (April 2005)
Volume 1, Issue 1, Pages (February 2002)
Volume 10, Issue 6, Pages (December 2006)
Volume 131, Issue 6, Pages (December 2006)
Array-CGH Reveals Recurrent Genomic Changes in Merkel Cell Carcinoma Including Amplification of L-Myc  Kelly G. Paulson, Bianca D. Lemos, Bin Feng, Natalia.
Volume 9, Issue 4, Pages (April 2006)
Discovery and Characterization of piRNAs in the Human Fetal Ovary
Volume 129, Issue 3, Pages (September 2005)
Learning More from Microarrays: Insights from Modules and Networks
Volume 146, Issue 6, Pages (September 2011)
Notch Activation as a Driver of Osteogenic Sarcoma
Hopping between Differentiation States in Lung Adenocarcinoma
Volume 17, Issue 1, Pages (January 2010)
Volume 29, Issue 5, Pages (May 2016)
Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence  Xiaoyu Qu, Claudio Jeldres, Lena Glaskova, Cynthia.
Large-Scale Analysis Reveals Acquisition of Lineage-Specific Chromosomal Aberrations in Human Adult Stem Cells  Uri Ben-David, Yoav Mayshar, Nissim Benvenisty 
Volume 32, Issue 1, Pages e4 (July 2017)
Volume 23, Issue 4, Pages (April 2018)
Suzanne Komili, Natalie G. Farny, Frederick P. Roth, Pamela A. Silver 
The Translational Landscape of the Mammalian Cell Cycle
Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma
Longitudinal Study of Recurrent Metastatic Melanoma Cell Lines Underscores the Individuality of Cancer Biology  Zoltan Pos, Tara L. Spivey, Hui Liu, Michele.
Volume 25, Issue 5, Pages e5 (October 2018)
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Volume 9, Issue 3, Pages (March 2006)
Volume 12, Issue 6, Pages (December 2003)
Daniel F. Tardiff, Scott A. Lacadie, Michael Rosbash  Molecular Cell 
Volume 11, Issue 10, Pages (June 2015)
The Prognostic Ease and Difficulty of Invasive Breast Carcinoma
Volume 5, Issue 4, Pages e4 (October 2017)
Volume 27, Issue 2, Pages (February 2015)
Mapping Cancer Origins
A DNA Replication Mechanism for Generating Nonrecurrent Rearrangements Associated with Genomic Disorders  Jennifer A. Lee, Claudia M.B. Carvalho, James.
Volume 129, Issue 3, Pages (September 2005)
Volume 5, Issue 4, Pages e4 (October 2017)
Volume 10, Issue 6, Pages (December 2006)
Volume 4, Issue 3, Pages e3 (March 2017)
Volume 29, Issue 5, Pages (May 2016)
Volume 122, Issue 6, Pages (September 2005)
Gene Density, Transcription, and Insulators Contribute to the Partition of the Drosophila Genome into Physical Domains  Chunhui Hou, Li Li, Zhaohui S.
Volume 7, Issue 2, Pages (August 2010)
Volume 110, Issue 4, Pages (August 2002)
James M. Flanagan, Sibylle Cocciardi, Nic Waddell, Cameron N
Volume 15, Issue 12, Pages (June 2016)
Patterns of Somatically Acquired Amplifications and Deletions in Apparently Normal Tissues of Ovarian Cancer Patients  Leila Aghili, Jasmine Foo, James.
Brandon Ho, Anastasia Baryshnikova, Grant W. Brown  Cell Systems 
Volume 26, Issue 12, Pages e5 (March 2019)
To Infinium, and Beyond! Cancer Cell
Volume 2, Issue 2, Pages (August 2002)
Volume 2, Issue 3, Pages (March 2016)
Volume 12, Issue 6, Pages (December 2007)
Volume 28, Issue 3, Pages e7 (July 2019)
Presentation transcript:

Volume 10, Issue 6, Pages 529-541 (December 2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies  Koei Chin, Sandy DeVries, Jane Fridlyand, Paul T. Spellman, Ritu Roydasgupta, Wen-Lin Kuo, Anna Lapuk, Richard M. Neve, Zuwei Qian, Tom Ryder, Fanqing Chen, Heidi Feiler, Taku Tokuyasu, Chris Kingsley, Shanaz Dairkee, Zhenhang Meng, Karen Chew, Daniel Pinkel, Ajay Jain, Britt Marie Ljung, Laura Esserman, Donna G. Albertson, Frederic M. Waldman, Joe W. Gray  Cancer Cell  Volume 10, Issue 6, Pages 529-541 (December 2006) DOI: 10.1016/j.ccr.2006.10.009 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Recurrent abnormalities in 145 primary breast tumors A: Frequencies of genome copy number gain and loss plotted as a function of genome location with chromosomes 1pter to the left and chromosomes 22qter and X to the right. Vertical lines indicate chromosome boundaries, and vertical dashed lines indicate centromere locations. Positive and negative values indicate frequencies of tumors showing copy number increases and decreases, respectively, with gain and loss as described in the Experimental Procedures. B: Frequencies of tumors showing high-level amplification. Data are displayed as described in A. C–J: Frequencies of tumors showing significant copy number gains and losses as defined in A (upper member of each pair) or high-level amplifications as defined in B (lower member of each pair) in tumor subtypes defined according to expression phenotype; C and D, basal-like; E and F, ERBB2; G and H, luminal A; I and J, luminal B. Data are displayed as described in A. Cancer Cell 2006 10, 529-541DOI: (10.1016/j.ccr.2006.10.009) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 Unsupervised hierarchical clustering of genome copy number profiles measured for 145 primary breast tumors Green indicates increased genome copy number, and red indicates decreased genome copy number. The three major genomic clusters from left to right are designated 1q/16q, complex, and amplifying. The bar to the left indicates chromosome locations with chromosome 1pter to the top and 22qter and X to the bottom. The locations of the odd-numbered chromosomes are indicated. The upper color bars indicate biological and clinical aspects of the tumors. Color codes are indicated at the bottom of the figure. Dark blue indicates positive status, and light blue indicates negative status for node, ER, PR, and p53 expression. For Ki67, dark blue indicates fraction >0.1, and light blue indicates fraction <0.1. For size, light blue indicates size <2.2 cm, and dark blue indicates size >2.2 cm. Color codes for the expression bar are as follows: orange, luminal A; dark blue, normal breast-like; light blue, ERBB2; green, basal-like; yellow, luminal B. Cancer Cell 2006 10, 529-541DOI: (10.1016/j.ccr.2006.10.009) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 Kaplan-Meyer plots showing survival in breast tumor subclasses A: Disease-specific survival in 130 breast cancer patients whose tumors were defined using expression profiling to be basal-like (green curve), luminal A (yellow curve), luminal B (orange curve), and ERBB2 (purple curve) class. B: Disease-specific survival of patients with tumors classified by genome copy number aberration analysis as 1q/16q (green), complex (red), and amplifying (blue). C: Survival of patients with (red curve) and without (green curve) amplification at any region of recurrent amplification. D: Survival of patients whose tumors were defined using expression profiling to be luminal A tumors with (red curve) and without (green curve) amplification at 8p11-12, 11q13, and/or 20q. E: Survival of patients whose tumors were not amplified at 8p11-12 and had normal (green curve) or reduced (red curve) genome copy number at 8p11-12. F: Survival of patients whose tumors had normal (green curve) or abnormal (red curve) genome copy number at 8p11-12. Cancer Cell 2006 10, 529-541DOI: (10.1016/j.ccr.2006.10.009) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 Results of unsupervised hierarchical clustering of 130 breast tumors using intrinsically variable gene expression but excluding any transcripts whose levels were significantly associated with genome copy number Red indicates increased expression, and green indicates reduced expression. An annotated version is provided as Figure S3. Cancer Cell 2006 10, 529-541DOI: (10.1016/j.ccr.2006.10.009) Copyright © 2006 Elsevier Inc. Terms and Conditions